Target intelligence / Profile preview

Estrogen receptor alpha, Estrogen receptor beta, G protein-coupled estrogen receptor 1 (ERα, ERβ, GPER1)

Target
ERα, ERβ, GPER1
Molecular classification
Nuclear receptor (ERα, ERβ), G protein-coupled receptor (GPER1)
01

Overview

Estrogen receptors are intracellular (ERα, ERβ) and membrane-bound (GPER1) protein molecules that bind estrogen hormones and regulate gene transcription and cellular signaling[1][2][3]. ERα and ERβ, encoded by ESR1 and ESR2 respectively, belong to the nuclear receptor family and operate mainly as ligand-activated transcription factors, mediating the genomic effects of estrogen in tissues such as breast, uterus, bone, and CNS. GPER1 is a membrane-associated, seven-transmembrane G protein-coupled receptor mediating rapid non-genomic estrogen signaling. Structural features include DNA-binding domains (which recognize estrogen response elements in gene promoters), ligand-binding domains, and transcriptional activation regions. Estrogen receptor function is essential for sexual development, reproductive tissue maintenance, and has roles in cell proliferation, differentiation, and survival. Aberrant estrogen receptor signaling contributes to diseases such as hormone-responsive cancers, cardiovascular disease, and osteoporosis[1][2][3][4].

Other names
ERαER-betaESR1ESR2GPERGPR30nuclear estrogen receptormembrane estrogen receptor
02

Mechanism of action

Agonism (activates receptor); Antagonism (blocks receptor); Selective modulation (SERMs: partial agonist/antagonist depending on tissue)

03

Biological functions

Transcription regulationSignal transductionCell proliferationApoptosisDifferentiationSurvivalVasodilationAutophagy
04

Disease associations

Cancer (especially breast and endometrial cancer)Cardiovascular diseaseOsteoporosisNeurodegenerative diseaseInflammation
05

Safety considerations

Thromboembolic risk (SERMs, estrogens)Cancer promotion (unopposed estrogen signaling)Cardiovascular adverse effectsEndometrial hyperplasia
06

Interacting drugs

Tamoxifen

6 more in the full profile.

07

Biomarkers

ERα protein expression (for breast cancer therapy selection)ERβ expression (in specific disease contexts)ESR1 mutation

Beyond the preview

Go deeper on Estrogen receptor alpha, Estrogen receptor beta, G protein-coupled estrogen receptor 1 (ERα, ERβ, GPER1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Estrogen receptor alpha, Estrogen receptor beta, G protein-coupled estrogen receptor 1 (ERα, ERβ, GPER1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call